Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Veru history
Veru company history timeline
“Casabe, et al., “”Efficacy and Safety of the Coadministration of Tadalafil Once Daily with Finasteride for 6 Months in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia””, The Journal of Urology, Volume 191, 727-733, March 2014.”
Mario Eisenberger, M.D. has served as a director of the Company since October 2016.
Doctor Hyun currently specializes in Pediatric Urology and serves as Clinical Associate Professor at NYU Langone School of Medicine, and Director, Pediatric Urology at NYU Langone Brooklyn Hospital since 2017.
Michael L. Rankowitz was elected director in March 2018.
MME LLC, Prostate Cancer Market Revenues (2018) “Delveinsight “Hot flashes associated with prostate cancer treatment: Market insights, epidemiology, and market forecast.
Grace S. Hyun, M.D. has served as a Director of the Company since August 2020.
Getzenberg, et al., “Determination of the ability of a novel, long-acting subcutaneous GnRH antagonist, VERU-100. to castrate without a testosterone surge in a rat model, GU ASCO Poster, 2020
Michael joined us as Executive Vice President, General Counsel & Corporate Strategy in March 2021.
ENTADFI™ (finasteride and tadalafil) capsule was approved by FDA in December 2021 to treat urinary tract symptoms caused by enlarged prostate called benign prostatic hyperplasia.
Prostate cancer is the most commonly diagnosed cancer in men with an estimated 268,490 new cases and 34,500 deaths expected for 2022 in the United States It is expected that one in eight men will develop prostate cancer in their lifetime.
Rate Veru's efforts to communicate its history to employees.
Veru jobs
Do you work at Veru?
Is Veru's vision a big part of strategic planning?
Veru history FAQs
Zippia gives an in-depth look into the details of Veru, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Veru. The employee data is based on information from people who have self-reported their past or current employments at Veru. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Veru. The data presented on this page does not represent the view of Veru and its employees or that of Zippia.
Veru may also be known as or be related to VERU INC., Veru and Veru Inc.